Frankfurt/Main (Germany), 17th September 2008-IonGate Biosciences GmbH announces the closing of a new round of funding amounting to EUR 1 million. The capital contribution comes in as the new investor Hessen Kapital I GmbH joins in a silent partnership with IonGate and it will be used for further expansion of the US business as well as for the increase of the global commercialization of SURFE2R Technology (SURFace Electrogenic Event Reader). After initializing its international marketing activities at the beginning of 2008, IonGate now advances on its way towards international market positioning. Following the foundation of IonGate Biosciences Inc. in January, the start of a co operation with the Japanese vendor BRC in March and of a strategic marketing partnership with US-based company ARTEL in June, IonGate’s next steps will follow: The raised fund will support IonGate’s US sales activities to meet the increasing demand for the recently launched SURFE2R Workstation 5000. Furthermore, the invested capital will push the development of the technology plat form and the SURFE2R product family. Hessen Kapital is a fund of the state of Hesse for Hessian medium-sized business to strenghten the companies’ equity base. Hessen Kapital joins as IonGate’s third investor, following Heidelberg Innovation and KfW.